anmelden
BX Swiss TOP 30 CHF
1.390,97
PKT
+23,54
PKT
+1,72
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09.02.11 | Holcim neutral | HSBC | |
| 09.02.11 | UBS buy | Vontobel Research | |
| 09.02.11 | Swiss Life buy | Vontobel Research | |
| 09.02.11 | Givaudan hold | Vontobel Research | |
| 09.02.11 | Julius Bär equal-weight | Morgan Stanley | |
| 08.02.11 | Givaudan hold | Vontobel Research | |
| 08.02.11 | Nestlé buy | Société Générale Group S.A. (SG) | |
| 08.02.11 | UBS buy | Vontobel Research | |
| 09.02.11 | UBS halten | Independent Research GmbH | |
| 08.02.11 | Lonza kaufen | Die Actien-Börse | |
| 07.02.11 | Julius Bär hold | Vontobel Research | |
| 04.02.11 | ABB (Asea Brown Boveri) sell | Société Générale Group S.A. (SG) | |
| 03.02.11 | Roche hold | Société Générale Group S.A. (SG) | |
| 03.02.11 | Holcim buy | Société Générale Group S.A. (SG) | |
| 07.02.11 | Roche kaufen | Hamburger Sparkasse AG (Haspa) | |
| 02.02.11 | Roche kaufen | Independent Research GmbH | |
| 01.02.11 | Geberit halten | Öko Invest | |
| 31.01.11 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
| 31.01.11 | Nestlé buy | ING | |
| 31.01.11 | Novartis buy | Vontobel Research | |
| 31.01.11 | ABB (Asea Brown Boveri) kaufen | Frankfurter Tagesdienst | |
| 28.01.11 | Logitech buy | Vontobel Research | |
| 28.01.11 | Novartis buy | Vontobel Research | |
| 27.01.11 | Lonza hold | Vontobel Research | |
| 27.01.11 | Zurich Insurance hold | Société Générale Group S.A. (SG) | |
| 27.01.11 | Novartis buy | SEB AG | |
| 27.01.11 | Logitech buy | Vontobel Research | |
| 27.01.11 | Novartis buy | Vontobel Research | |
| 28.01.11 | Novartis kaufen | Independent Research GmbH | |
| 26.01.11 | ABB (Asea Brown Boveri) kaufen | Hamburger Sparkasse AG (Haspa) | |
| 26.01.11 | ABB (Asea Brown Boveri) halten | Independent Research GmbH | |
| 26.01.11 | Julius Bär overweight | Morgan Stanley | |
| 26.01.11 | Lonza hold | Vontobel Research | |
| 26.01.11 | ABB (Asea Brown Boveri) hold | Vontobel Research | |
| 24.01.11 | Novartis buy | Vontobel Research | |
| 24.01.11 | Sonova hold | Vontobel Research | |
| 25.01.11 | Novartis kaufen | Independent Research GmbH | |
| 21.01.11 | UBS buy | Vontobel Research | |
| 21.01.11 | Kühne + Nagel International hold | Vontobel Research | |
| 21.01.11 | UBS buy | Vontobel Research |